FERMENTALG (EPA:FALG) | WebDisclosure

Basculer en Français

10153	Companies
208570	Keywords
138661	Articles
110536	Press releases

Home
Companies
FERMENTALG

BRIEF

published on 04/02/2026 at 18:05, 20 minutes ago

Résultats financiers de Fermentalg pour 2025 : Forte hausse des ventes et solidité financière

FERMENTALG BioSolutions Résultats De 2025 Prêt Huvepharma ΩRIGINS™ Et Galdieria Blue
BRIEF

published on 04/02/2026 at 18:05, 20 minutes ago

Fermentalg: 2025 Review and 2026 Outlook

Treasury Growth FERMENTALG 2025 Results BioSolutions
BRIEF

published on 04/02/2026 at 18:05, 20 minutes ago

Fermentalg's 2025 Financial Results: Sales Surge and Strengthened Financials

FERMENTALG 2025 Results BioSolutions Huvepharma Loan ΩRIGINS™ & Galdieria Blue
BRIEF

published on 04/02/2026 at 18:05, 20 minutes ago

Fermentalg : Bilan 2025 et Perspectives 2026

Croissance Trésorerie FERMENTALG Résultats 2025 BioSolutions
PRESS RELEASE

published on 04/02/2026 at 18:00, 25 minutes ago

2025 Annual Results: Strong sales growth, expansion of the customer portfolio and BioSolutions, and strengthening of the financial structure thanks to Huvepharma
Fermentalg reports a record 2025 turnover of €13.4 million, stable operating profit, post-closing loan from Huvepharma, promising outlook with new product launches, and a target of €20 million revenue by 2026

Product Launches Revenue Target FERMENTALG 2025 Turnover Huvepharma Loan
PRESS RELEASE

published on 04/02/2026 at 18:00, 25 minutes ago

Résultats annuels 2025 : Forte croissance des ventes, enrichissement du portefeuille clients et de BioSolutions, renforcement de la structure financière grâce à Huvepharma
Fermentalg annonce un chiffre d'affaires record en 2025, une stabilité du résultat opérationnel, un renforcement de la trésorerie grâce à un prêt de 4 M€ d'Huvepharma, et des perspectives prometteuses avec de nouveaux lancements

Chiffre D'affaires Résultat Opérationnel Perspectives Trésorerie FERMENTALG
BRIEF

published on 03/16/2026 at 11:05, 17 days 7 hours ago

Feu vert de l'EFSA pour le colorant Galdieria Blue de Fermentalg

Commercialisation FERMENTALG Microalgues EFSA Galdieria Blue
BRIEF

published on 03/16/2026 at 11:05, 17 days 7 hours ago

EFSA Approves Fermentalg’s Natural Blue Colorant for European Market

Commercialization FERMENTALG EFSA Galdieria Blue Food Additive
BRIEF

published on 03/16/2026 at 11:05, 17 days 7 hours ago

EFSA gives green light to Fermentalg's Galdieria Blue colorant

Marketing FERMENTALG Microalgae EFSA Galdieria Blue
BRIEF

published on 03/16/2026 at 11:05, 17 days 7 hours ago

L'EFSA approuve le colorant bleu naturel de Fermentalg pour le marché européen

Commercialisation FERMENTALG EFSA Bleu De Galdieria Additif Alimentaire

Accesswire

Published on 04/02/2026 at 15:00, 3 hours 25 minutes ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 3 hours 45 minutes ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 3 hours 55 minutes ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/02/2026 at 14:10, 4 hours 15 minutes ago

Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care
Published on 04/02/2026 at 14:00, 4 hours 25 minutes ago

Electrovaya Collaborates on U.S. Department of Energy-Funded Project to Advance Energy Storage for Critical Infrastructure

View all ACCESSWIRE

EQS Group

Published on 04/02/2026 at 17:45, 40 minutes ago

Minority Shareholders of DKSH Holdings (Malaysia) Berhad Reject Take-Over Offer by DKSH Holding Ltd. at Extraordinary General Meeting
Published on 04/02/2026 at 17:28, 57 minutes ago

hep global GmbH recommends approving the jointly agreed, amended resolution proposal of SdK in the voting without a meeting from 12 to 14 April 2026
Published on 04/02/2026 at 17:27, 57 minutes ago

DSH-Director/PDMR Shareholding
Published on 04/02/2026 at 16:10, 2 hours 14 minutes ago

The Adelaïde Group continued on its growth path in 2025 and consolidated the foundations of its European expansion
Published on 04/02/2026 at 15:32, 2 hours 52 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

Les Echos

Published on 04/02/2026 at 18:00, 25 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of March 27, 2026
Published on 04/02/2026 at 18:00, 25 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 27 mars 2026
Published on 04/02/2026 at 18:00, 25 minutes ago

ICADE – PR – Availability of the 2025 URD
Published on 04/02/2026 at 18:00, 25 minutes ago

ICADE – CP – Mise à disposition du DEU 2025
Published on 04/02/2026 at 17:45, 40 minutes ago

Informations relatives au nombre total de droits de vote et d’actions

View all LES ECHOS COMFI WIRE